IPF Archives -

BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has added to its

BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone

https://pharmaphorum.com/news/benevolentai-astrazeneca-ai-based-drug-discovery-collaboration-achieves-third-milestone/

5th Antifibrotic Drug Development Summit -AFDD-

https://pharmaphorum.com/events/5th-antifibrotic-drug-development-summit-afdd/

Privately-held biotech Galecto has raised $64m with an equity funding round to further research into treatments for drugs

Galecto raises $64m to finance EU filing for inhaled IPF drug

https://pharmaphorum.com/news/galecto-raises-64m-to-finance-eu-filing-for-inhaled-ipf-drug/

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to

Redx shares soar after IPF drug licence deal with AstraZeneca

https://pharmaphorum.com/news/redx-shares-soar-after-ipf-drug-deal-with-astrazeneca/

Boehringer Ingelheim and South Korean biotech Bridge Biotherapeutics have announced a deal to develop the latter’s drug for

Boehringer announces IPF deal with Korea’s Bridge Biotherapeutics

https://pharmaphorum.com/news/boehringer-announces-ipf-deal-with-koreas-bridge-therapeutics/

Boehringer Ingelheim has filed for a new use for its lung drug nintedanib in the US and Europe,

Boehringer files for new rare disease use for nintedanib in EU, US

https://pharmaphorum.com/news/boehringer-files-for-new-rare-disease-use-for-nintedanib-in-eu-us/

Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.

Biomarker trial to show drug value in rare lung disease

https://pharmaphorum.com/news/biomarker-trial-show-drug-value-rare-lung-disease/

Idiopathic pulmonary fibrosis (IPF) is a fatal disease that’s all the more difficult for patients because of a

Patient perspective: living with rare lung disease IPF

https://pharmaphorum.com/views-and-analysis/patient-perspective-living-with-rare-lung-disease-ipf/

IPF